Conduit Pharmaceuticals (CDT) Stock Chart & Stock Price History → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free CDT Stock Alerts $3.03 +0.06 (+2.02%) (As of 02:58 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Conduit Pharmaceuticals Stock Price Performance5 Day Performance+2.02%1 Month Performance-1.94%3 Month Performance+1.34%6 Month Performance+158.80%Year-To-Date Performance-33.41% Receive CDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. CDT Stock Chart for Thursday, May, 16, 2024 CDT Chart by TradingView Conduit Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$2.84$2.97+4.58%$3.07$2.8312,511 shs$219.28 million05/14/2024$3.09$2.84-8.09%$3.15$2.8048,048 shs$209.68 million05/13/2024$2.97$3.09+4.04%$3.13$2.9520,492 shs$228.14 million05/10/2024$3.04$2.97-2.30%$3.25$2.9733,702 shs$219.28 million05/09/2024$2.95$3.04+3.05%$3.19$3.0419,184 shs$224.44 million05/08/2024$3.21$2.95-8.10%$3.22$2.8533,482 shs$217.80 million Get the Latest News and Ratings for CDT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$3.08$3.21+4.22%$3.50$3.1117,799 shs$236.99 million05/06/2024$3.00$3.08+2.67%$3.21$3.0812,989 shs$227.40 million05/03/2024$2.99$3.00+0.33%$3.22$2.9914,194 shs$221.49 million05/02/2024$2.82$2.99+6.03%$3.13$2.9210,392 shs$220.75 million05/01/2024$3.01$2.82-6.31%$3.22$2.827,947 shs$208.20 million04/30/2024$3.34$3.01-9.88%$3.49$3.0150,553 shs$222.23 million04/29/2024$3.17$3.34+5.36%$3.34$3.1018,340 shs$246.59 million04/26/2024$3.10$3.17+2.26%$3.17$3.055,588 shs$230.81 million04/25/2024$3.18$3.10-2.52%$3.20$3.0814,691 shs$225.71 million04/24/2024$3.15$3.18+0.95%$3.20$3.1021,389 shs$231.54 million04/23/2024$3.08$3.15+2.27%$3.15$3.0814,243 shs$229.35 million04/22/2024$3.12$3.08-1.28%$3.15$3.085,092 shs$224.26 million04/19/2024$2.99$3.12+4.35%$3.17$2.9213,040 shs$227.17 million04/18/2024$2.97$2.99+0.67%$3.23$2.9531,335 shs$217.71 million04/17/2024$3.09$2.97-3.88%$3.22$2.9315,014 shs$216.25 million04/16/2024$3.22$3.09-4.04%$3.23$3.0022,147 shs$224.98 million04/15/2024$3.18$3.22+1.26%$3.24$3.0818,552 shs$234.45 million04/12/2024$3.19$3.18-0.31%$3.18$2.932,646 shs$231.54 million04/11/2024$3.10$3.19+2.90%$3.24$3.1017,196 shs$232.26 million04/10/2024$3.17$3.10-2.21%$3.23$2.7630,604 shs$225.71 million04/09/2024$3.25$3.17-2.46%$3.27$3.0316,691 shs$230.81 million04/08/2024$3.26$3.25-0.31%$3.29$2.9716,382 shs$236.65 million04/05/2024$3.27$3.26-0.31%$3.30$3.1118,457 shs$237.36 million04/04/2024$3.34$3.27-2.10%$3.33$3.1717,791 shs$238.10 million04/03/2024$3.43$3.34-2.62%$3.35$3.2222,491 shs$243.19 million04/02/2024$3.51$3.43-2.28%$3.60$3.1127,880 shs$249.74 million04/01/2024$3.67$3.51-4.36%$3.79$3.4413,936 shs$255.56 million03/29/2024$3.67$3.67$3.92$3.3533,077 shs$267.23 million03/28/2024$3.57$3.67+2.80%$3.92$3.3533,077 shs$267.21 million03/27/2024$3.41$3.57+4.69%$3.64$3.2832,846 shs$259.93 million03/26/2024$3.35$3.41+1.79%$3.41$3.1534,816 shs$248.28 million03/25/2024$3.30$3.35+1.52%$3.48$3.1247,046 shs$243.91 million03/22/2024$3.45$3.30-4.35%$3.70$3.1138,119 shs$240.27 million03/21/2024$3.47$3.45-0.43%$3.67$3.1244,492 shs$251.19 millionA ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now.03/20/2024$3.18$3.47+8.96%$3.49$3.1420,686 shs$252.29 million03/19/2024$3.16$3.18+0.63%$3.37$3.0565,745 shs$231.55 million03/18/2024$3.53$3.16-10.48%$3.51$3.0721,909 shs$230.08 million03/15/2024$3.18$3.53+11.01%$3.53$3.1470,858 shs$257.02 million03/14/2024$3.09$3.18+2.91%$3.18$3.0517,919 shs$231.55 million03/13/2024$3.42$3.09-9.65%$3.29$2.9333,388 shs$224.98 million03/12/2024$3.68$3.42-7.07%$3.71$3.4083,287 shs$249.01 million03/11/2024$2.78$3.68+32.37%$3.69$2.78134,635 shs$267.94 million03/08/2024$2.65$2.78+4.91%$2.85$2.6640,217 shs$202.41 million03/07/2024$2.75$2.65-3.64%$2.72$2.6525,078 shs$192.95 million03/06/2024$2.77$2.75-0.72%$2.80$2.6532,436 shs$200.23 million03/05/2024$2.69$2.77+2.97%$2.78$2.5147,433 shs$201.70 million03/04/2024$2.59$2.69+3.86%$2.78$2.5118,893 shs$195.86 million03/01/2024$2.57$2.59+0.78%$3.00$2.5921,960 shs$188.58 million02/29/2024$2.85$2.57-9.82%$3.00$2.5613,880 shs$207.52 million02/28/2024$2.97$2.85-4.04%$3.01$2.6525,993 shs$207.51 million02/27/2024$3.14$2.97-5.41%$3.34$2.9043,423 shs$216.25 million02/26/2024$2.81$3.14+11.74%$3.14$2.8039,803 shs$228.62 million02/23/2024$2.83$2.81-0.71%$3.11$2.7749,067 shs$204.60 million02/22/2024$2.65$2.83+6.79%$2.84$2.6624,504 shs$206.05 million02/21/2024$2.92$2.65-9.25%$3.05$2.6142,287 shs$192.95 million02/20/2024$2.99$2.92-2.34%$3.08$2.8027,818 shs$212.61 million02/19/2024$2.99$2.99$3.10$2.7625,500 shs$217.70 million02/16/2024$3.05$2.99-1.97%$3.10$2.7625,516 shs$217.70 million02/15/2024$3.18$3.05-4.09%$3.26$2.9419,157 shs$222.08 million Related Companies: 2seventy bio Stock Price Chart Puma Biotechnology Stock Price Chart Eliem Therapeutics Stock Price Chart Aldeyra Therapeutics Stock Price Chart Merrimack Pharmaceuticals Stock Price Chart uniQure Stock Price Chart Omeros Stock Price Chart Foghorn Therapeutics Stock Price Chart G1 Therapeutics Stock Price Chart Ovid Therapeutics Stock Price Chart Receive CDT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.